Influence of the catalyst type (TiO2 and zno) on the photocatalytic oxidation of pharmaceuticals in the aquatic environment

Desalination and Water Treatment

Volumn 57, Issue 3, 2016, Pages 1552-1563

  Bohdziewicz, Jolanta ^a   Kudlek, Edyta ^a   Dudziak, Mariusz ^a  

^a SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Oxidation by products; Pharmaceutical compounds; Photocatalysis; Toxicity

Indexed keywords

AQUATIC ENVIRONMENT; CATALYSIS; CATALYST; OXIDATION; PHOTOCHEMISTRY; PPCP; TOXICITY;

EID: 84916619983     PISSN: 19443994     EISSN: 19443986     Source Type: Journal    
DOI: 10.1080/19443994.2014.988411     Document Type: Article

References (45)

1. N. De la Cruz, J. Giménez, S. Esplugas, D. Grandjean, L.F. De Alencastro, C. Pulgarín, Degradation of 32 emergent contaminants by UV and neutral photo-fenton in domestic wastewater effluent previously treated by activated sludge, Water Res. 46 (2012) 1947-1957.
2. S.D. Richardson, T.A. Ternes, Water analysis: Emerging contaminants and current issues, Anal. Chem. 83 (2011) 4616-4648.
3. I. Oller, S. Malato, J.A. Sánchez-Pérez, Combination of advanced oxidation processes and biological treatments for wastewater decontamination—A review, Sci. Total Environ. 409 (2011) 4141-4166.
4. 2 photocatalysis of the pharmaceutical propranolol: Solar and artificial light, Appl. Catal., B, 130-131 (2013) 249-256.
5. L.H.M.L.M. Santos, A.N. Arau´ jo, A. Fachini, A. Pena, C. Delerue-Matos, M.C.B.S.M. Montenegro, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J. Hazard. Mater., 175 (2010) 45-95.
6. T.A. Ternes, M. Meisenheimer, D. Mc Dowell, H.J. Bauch, B. Haist-Gulde, G. Preus, U. Wilme, N. Zulei-Seibert, Removal of pharmaceuticals during drinking water treatment, Environ. Sci. Technol. 36 (2002) 3855-3863.
7. S. Mompelat, B. Le Bot, O. Thomas, Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water, Environ. Int. 35 (2009) 803-814.
8. P.E. Stackelberg, E.T. Furlong, M.T. Meyer, S.D. Zaug, A.K. Henderson, D.B. Reissman, Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water treatment plant, Sci. Total Environ. 329 (2004) 99-113.
9. N.M. Vieno, H. Härkki, T. Tuhkanen, L. Kronberg, Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant, Environ. Sci. Technol. 41 (2007) 5077-5084.
10. N.A. Doerr-MacEwen, M.E. Haight, Expert stakeholders’ views on the management of human pharmaceuticals in the environment, Environ. Manage. 38 (2006) 853-866.
11. I. Pountos, T. Georgouli, H. Bird, P.V. Giannoudis, Nonsteroidal anti-inflammatory drugs: Prostaglandins, indications, and side effects, Int. J. Infereron Cytokine Mediator Res. 3 (2011) 19-27.
12. J. Schwaiger, H. Ferling, U. Mallow, H. Wintermayr, R.D. Negele, Toxic effects of the non-steroidal antiinflammatory drug diclofenac. Part I: Histopathological alterations and bioaccumulation in rainbow trout, Aquat. Toxicol. 68 (2004) 145-150.
13. R. Triebskorn, H. Casper, A. Heyd, R. Eikemper, H.R. Kohler, J. Schwaiger, Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout, Aquat. Toxicol. 68 (2004) 151-166.
14. B. Hoeger, B. Kollner, D.R. Dietrich, B. Hitzfeld, Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario), Aquat. Toxicol. 75 (2005) 53-64.
15. M.E. DeLorenzo, J. Fleming, Individual and mixture effects of selected pharmaceuticals and personal care products on the marine phytoplankton species Dunaltella terttolecta, Arch. Environ. Contam. Toxicol. 54 (2008) 203-210.
16. J.L. Flippin, D. Huggett, C.M. Foran, Changes in the timing of reproduction following chronic exposure to ibuprofen in Japanese medaka, Oryzias latipes, Aquat. Toxicol. 81 (2007) 73-78.
17. H.J. De Lange, W. Noordoven, A.J. Murk, M. Lurling, E.T.H.M. Peeters, Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals, Aquat. Toxicol. 78 (2006) 209-216.
18. F. Pomati, A.G. Netting, D. Calmari, B.A. Neilan, Effects of erythromycin, tetraycline and ibuprofen on the growth of Synechocysts sp. and Lemna minor, Aquat. Toxicol. 67 (2004) 387-396.
19. B. Ferrari, N. Paxéus, R.L. Giudice, A. Pollio, J. Garric, Ecotoxicological impact of pharmaceuticals found in treated wastewaters: Study of carbamazepine, clofibric acid, and diclofenac, Ecotoxicol. Environ. Saf. 55 (2003) 359-370.
20. C. Zwiener, F.H. Frimmel, Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac, Sci. Total Environ. 309 (2003) 201-211.
21. J.T. Yu, E.J. Bouwer, M. Coelhan, Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent, Agric. Water Manage. 86 (2006) 72-80.
22. N. Vieno, T. Tuhkanen, L. Kronberg, Elimination of pharmaceuticals in sewage treatment plants in Finland, Water Res. 41 (2007) 1001-1012.
23. M.J. Benotti, B.J. Brownawell, Distributions of pharmaceuticals in an urban estuary during both dry-and wet-weather conditions, Environ. Sci. Technol. 41 (2007) 5795-5802.
24. J.L. Santos, I. Aparicio, E. Alonso, Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain), Environ. Int. 33 (2007) 596-601.
25. I. Skoczko, J. Piekutin, Fhoto-Fenton method usage to organic compounds degradation, Desalin. Water Treat. 52 (2014) 3837-3842.
26. A. Joss, S. Zabaczynski, A. Göbel, B. Hoffmann, D. Löffler, C.S. McArdell, T.A. Ternes, A. Thomsen, H. Siegrist, Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme, Water Res. 40 (2006) 1686-1696.
27. E. Isarain-Chavez, R.M. Rodriguez, P.L. Cabot, F. Centellas, C. Arias, J.A. Garrido, E. Brillas, Degradation of pharmaceutical beta-blockers by electrochemical advanced oxidation processes using a flow plant with a solar compound parabolic collector, Water Res. 45 (2011) 4119-4130.
28. S. Hussain, S. Shaikh, M. Farooqui, COD reduction of waste water streams of active pharmaceutical ingredient— Atenolol manufacturing unit by advanced oxidation-Fenton process, J. Saudi Chem. Soc. 17 (2013) 199-202.
29. S.B. Abdelmelek, J. Greaves, K.P. Ishida, W.J. Cooper, W. Song, Removal of pharmaceutical and personal care products from reverse osmosis retentate using advanced oxidation processes, Environ. Sci. Technol. 45 (2011) 3665-3671.
30. E. Brillas, I. Sires, M.A. Oturan, Electro-Fenton process and related electrochemical technologies based on Fenton’s reaction chemistry, Chem. Rev. 109 (2009) 6570-6631.
31. L.C. Almeida, S. Garcia-Segura, N. Bocchi and E. Brillas, Solar photoelectro-Fenton degradation of paracetamol using a flow plant with a Pt/air-diffusion cell coupled with a compound parabolic collector: Process optimization by response surface methodology, Appl. Catal., B, 103 (2011) 21-30.
32. A. Chatzitakis, C. Berberidou, I. Paspaltsis, G. Kyriakou, T. Sklaviadis, I. Poulios, Photocatalytic degradation and drug activity reduction of chloramphenicol, Water Res. 42 (2008) 386-394.
33. 2-assisted photocatalytic degradation of azo dyes in aqueous solution: Kinetic and mechanistic investigations. A review, Appl. Catal., B, 49 (2004) 1-14.
34. M.N. Chong, B. Jin, C.W.K. Chow, C. Saint, Recent developments in photocatalytic water treatment technology: A review, Water Res. 44 (2010) 2997-3027.
35. J. Bohdziewicz, E. Kudlek-Jelonek and M. Dudziak, Determination of pharmaceutical residues in the water environment by means of HPLC (UV) and GC-MS (EI) technique, in: R. Michalski (Ed.), Ion Chromatography 2014, Institute of Environmental Engineering PAS, Zabrze 2014, pp. 250-262 (in Polish).
36. M. Dudziak, M. Rajca, The photocatalytic oxidation of zearalenone and high molecular weight organic substances in water solutions, Instal 5 (2011) 24-26 (in Polish).
37. K. Vasanth Kumar, K. Porkodi, F. Rocha, Langmuir-Hinshelwood kinetics-A theoretical study, Catal. Commun. 9 (2008) 82-84.
38. J. Marugán, D. Bru, C. Pablos, M. Catalá, Comparative evaluation of acute toxicity by Vibrio fischeri and fern spore based bioassays in the follow-up of toxic chemicals degradation by photocatalysis, J. Hazard. Mater. 213-214 (2012) 117-122.
39. S. Trajkovska, M. Mbaye, M.D. Gaye Seye, J. Aaron, M. Chevreuil, H. Blanchoud, Toxicological study of pesticides in air and precipitations of Paris by means of a bioluminescence method, Anal. Bioanal. Chem. 394 (2009) 1099-1106.
40. 2 photocatalysis: UV absorbance kinetics and process evaluation through a set of toxicity bioassays, Water Res. 43 (2009) 979-988.
41. J.K. Im, H.S. Son, Y.M. Kang, K.D. Zoh, Carbamazepine degradation by photolysis and titanium dioxide photocatalysis, Water Environ. Res. 84 (2012) 554-561.
42. M.N. Chonga, B. Jin, Photocatalytic treatment of high concentration carbamazepine in synthetic hospital wastewater, J. Hazard. Mater. 199-200 (2012) 135-142.
43. 2 and ZnO: Effect of pH, ionic strength, and natural organic matter, Sci. Total Environ. 475 (2014) 16-22.
44. 2 and ZnO nanoparticles for photocatalytic degradation of methylene blue and the correlated inactivation of gram-positive and gram-negative bacteria, J. Nanopart. Res. 15 (2013) 1432-1442.
45. S. Werle, M. Dudziak, Evaluation of toxicity of sewage sludge and gasification waste-products, Chem. Rev., 92 (2013) 1350-1353 (in Polish).